OPRX News and Press, OptimizeRx Corporation

WALTHAM, Mass., June 30, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at the most important decision poi...

WALTHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and patients at the most important decision points, t...

2026-06-11 14:48:23 ET OptimizeRx (NASDAQ: OPRX) , a provider of healthcare technology solutions for life sciences companies, announced that it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility consists of a $25 million term...

WALTHAM, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that management will partici...

WALTHAM, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and patients at the most important decision points, today announced that  Deep...

2026-05-14 15:24:42 ET Image source: The Motley Fool. Tuesday, May 12, 2026, at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-05-13 10:15:12 ET from Lake Street issued a price target of $11.00 for OPRX on 2026-05-13 12:49:22. The adjusted price target was set to $11.00. At the time of the announcement, OPRX was trading at $4.855. The overall price target consensus is at $10.50 with high pr...

2026-05-12 20:31:35 ET More on OptimizeRx OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call Transcript OptimizeRx: Q4 Earnings Report Indicates Caution For 2026 OptimizeRx Corporation (OPRX) Q4 2025 Earnings Call Transcript OptimizeRx Q1 2026 Earnings Previ...

2026-05-12 20:30:45 ET OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call May 12, 2026 4:30 PM EDT Company Participants Stephen Silvestro - CEO & Director Edward Stelmakh - Chief Financial & Strategic Officer Andrew D'Silva - Chief Business Officer ......

2026-05-12 16:17:23 ET More on OptimizeRx OptimizeRx: Q4 Earnings Report Indicates Caution For 2026 OptimizeRx Corporation (OPRX) Q4 2025 Earnings Call Transcript OptimizeRx Q1 2026 Earnings Preview OptimizeRx signals $109M-$114M revenue target for 2026 as ma...